Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing RulesBusiness Wire • 6 days agoForte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the issuance of equity...